ZINZINO AB (PUBL): PRELIMINARY SALES REPORT APRIL 2021

Strong sales growth during April; Zinzino group revenue increased with a total of 21%, compared with the previous year.

The revenue in April for Zinzino's sales markets increased by 17% to SEK 98.7 (84.2) million due to strong growth in several regions. Faun Pharma's external sales increased by 97% and amounted to SEK 7.5 (3.8) million. Overall, the Group increased revenues by 21% to SEK 106.2 (88.0) million compared with the previous year.

Accumulated revenue for January – April 2021 increased by 33% SEK 439.7 (330.2) million.

Revenues were distributed as follows:

Regions,MSEK 21-Apr 20-Apr Change YTD 2021 YTD 2020 Change
The Nordics 29.0 31.5 -8% 123.1 127.8 -4%
Central Europe 16.9 13.4 26% 70.9 48.4 46%
East Europe 26.4 24.0 10% 107.5 80.2 34%
South & West Europe 11.4 5.1 124% 44.9 17.3 160%
The Baltics 5.8 5.7 2% 24.5 22.4 9%
North America 3.7 3.0 23% 18.3 11.5 59%
Asia-Pacific 5.5 1.5 267% 25.7 5.3 385%
Zinzino 98.7 84.2 17% 414.9 312.87 33%
Faun Pharma 7.5 3.8 97% 24.8 17.3 43%
Zinzino Group 106.2 88.0 21% 439.7 330.2 33%
 

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

-Central Europe: Austria, Germany, Switzerland

-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Netherlands, Spain, United Kingdom

-The Baltics: Estonia, Latvia, Lithuania

-North America: Canada, USA

-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand

 

For more information: Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

 

Pictures for publication free of charge: Marcus Tollbom +46 (0) 70 190 03 12, marcus.tollbom@zinzino.com

 

Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se

 

Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 13:00 the 4th of May 2021.

Zinzino AB (publ.) is a global direct sales company that markets and sells test-based nutrition, skincare and life-style products. Zinzino owns the research unit BioActive Foods AS and production unit Faun Pharma AS. Zinzino is based in Gothenburg, Sweden with additional offices in Finland, Latvia, Norway, USA, Australia, Hong Kong and Malaysia. Zinzino is a public company and its shares are listed on Nasdaq First North Premier Growth Market.

Tags:

Subscribe

Media

Media